Efficient modification of <i>CCR5</i> in primary human hematopoietic cells using a megaTAL nuclease and AAV donor templateBlythe Sather, David J. Rawlings, Guillermo S. Romano Ibarra et al.|Science Translational Medicine|2015Cited by 231
Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T CellsMalika Hale, Thor A. Wagner, Taylor D. Mesojednik et al.|Molecular Therapy|2017Cited by 169
761. Targeted Killing of HIV Infected Cells Using CCR5-Disrupted Anti-HIV-CAR T CellsGuillermo S. Romano Ibarra, Thor A. Wagner, Malika Hale et al.|Molecular Therapy|2016Cited by 2
685. Efficient Targeted Gene Modification in Primary Human Hematopoietic Cells Using Co-Delivery of Nuclease mRNA and AAV DonorsGuillermo S. Romano Ibarra, David J. Rawlings, Gabrielle Curinga et al.|Molecular Therapy|2015Cited by 0
284. High-Efficiency Targeted Introduction of an Anti-CD19 CAR Into the CCR5 Locus in Primary Human T CellsMalika Hale, David J. Rawlings, Guillermo S. Romano Ibarra et al.|Molecular Therapy|2015Cited by 0